How Did DePuy Decide To Issue The ASR Hip Recall?
Monday, February 28th, 2011The fact that the problems stemming from the DePuy hip replacement recall were not revealed by sources within the United States might come as a surprise to you. An Australian joint registry first took notice of these problems relating to the implants’ higher than usual failure rate.
As the lawsuits against Johnson & Johnson division, DePuy Orthopaedics pile up, much chagrin have emanated from the blatant disregard of the company to recall their defective hip replacement devices when they discovered significant data about them. Data revealed from different sources were what urged the company to withdraw the ASR XL Acetabular System and the ASR Hip Resurfacing System from the global market in August.
Telling grounds back up these claims. Starting in 2008, the U.S. Food and Drugs Administration has received an estimated 300 complaints against the DePuy hip replacement devices. Director of the Australian National Joint Replacement Registry, Professor Stephen Graves informed the company of the present failure rate of their hip implants. In fact, Professor Graves and the Registry were alarmed enough to have warned the orthopedic manufacturer seven times. About a year before recalling the DePuy hip devices from the global market, the company have already given a recall order in Australia.
Even though DePuy Orthopaedics is still responsible for the fiasco, some say that the recall would have been declared earlier had the the United States possessed a program like the Australian National Joint Replacement Registry.
The same thing would less likely happen again in the wake of the conception of the American Joint Replacement Registry by the American Academy of Orthopedic Surgeons. In October, 15 hospitals in the nation have commenced the start of its pilot programs. Following and monitoring hip replacement implants embedded by surgeons are duties of the program. “The advantages of a registry are many. You can pool patients, provide contemporary information and do postmarket surveillance. It can lead to evidence-based practice, generate research questions and be, in and of itself, a research tool,” declares orthopedic surgeon Dr. William J. Maloney. At most, a 10% decrease in the need for revision surgery were noted by similar registries in Sweden, Great Britain, Canada, and Australia.
Substantial data disclosed by the National Joint Registry for England and Wales was what urged DePuy to issue a hip recall on their products worldwide. The founding of the AJRR would be beneficial in discovering similar problems in the future. One thing is certain still, DePuy’s oversight have made plenty of people suffer. DePuy should be made to compensate the losses you endured and a hip replacement lawyer can increase your chances of acquiring it.